EVALUATION OF CHANGES IN INTERLEUKIN-4 LEVELS WHEN USING THE IMMUNOMODULATOR GEPON IN THE TREATMENT OF PATIENTS WITH CUTANEOUS LEISHMANIASIS

Observations were carried out in 43 patients with cutaneous (zoonotic) leishmaniasis aged 2 to 44 years. In all infected patients, the diagnosis of cutaneous (zoonotic) leishmaniasis was confirmed by clinical, epidemiological and parasitological methods.

In 10 healthy individuals, 12 patients with cutaneous leishmaniasis who received conventional medical treatment (control group) and 43 patients after 15 days of local and oral administration of Gepon immunomodulator (main group patients), the levels of Interleukin-4 in the blood were studied. showed changes.